1Q Results (Jan 12 - Mar 12) Conference Call

from the beginning

FY2012 1Q Consolidated Financial Overview

presenter :

Yoshio Itaya,
Executive Vice President CFO

Forward-Looking Statements

Summary

Financial Overview Jan Mar

Sales (excl Tamiflu) Jan Mar

Tamiflu Sales Performance

Operating Income Jan Mar

Overview

Major Product Update

presenter :

Masaaki Tohaya,
Senior Vice President,
General Manager of Sales Div.

Avastin

Xeloda

Edirol

Actemra (Domestic Sales)

Epogin / Mircera

Pegasys / Copegus

Overview of Development Pipeline

presenter :

Hisanori Takanashi,
Department Manager of R&D Portfolio
Management Dept.

Development Status - Oncology

Development Status - Autoimmune, CNS

Q&A

• Q&A1

• Q&A2

• Q&A3

• Q&A4

• Q&A5

• Q&A6

• Q&A7

• Q&A8

@